A. Islam, Tanveer Ahmed, I. J. Shimu, S. Nahar, Mohammad Arifur Rahman, Afzalur Rahman
{"title":"缺血性心脏病患者的特发性血小板减少性紫癜-治疗挑战","authors":"A. Islam, Tanveer Ahmed, I. J. Shimu, S. Nahar, Mohammad Arifur Rahman, Afzalur Rahman","doi":"10.3329/BHJ.V33I1.37029","DOIUrl":null,"url":null,"abstract":"Idiopathic thrombocytopenic purpura (ITP) and myocardial infarction (MI) in an individual patient is a rare combination. MI mandates thrombolytic and antiplatelet therapy which increases the risk of bleeding in ITP. So far, no guideline deals with management protocol for ischaemic heart disease (IHD) in ITP patients. Here, we describe 2 cases of IHD who developed ITP while on antiplatelet therapy.Bangladesh Heart Journal 2018; 33(1) : 74-77","PeriodicalId":247590,"journal":{"name":"Bangladesh Heart Journal","volume":"6 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2018-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Idiopathic Thrombocytopenic Purpura in Patients with Ischaemic Heart Disease - A Therapeutic Challenge\",\"authors\":\"A. Islam, Tanveer Ahmed, I. J. Shimu, S. Nahar, Mohammad Arifur Rahman, Afzalur Rahman\",\"doi\":\"10.3329/BHJ.V33I1.37029\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Idiopathic thrombocytopenic purpura (ITP) and myocardial infarction (MI) in an individual patient is a rare combination. MI mandates thrombolytic and antiplatelet therapy which increases the risk of bleeding in ITP. So far, no guideline deals with management protocol for ischaemic heart disease (IHD) in ITP patients. Here, we describe 2 cases of IHD who developed ITP while on antiplatelet therapy.Bangladesh Heart Journal 2018; 33(1) : 74-77\",\"PeriodicalId\":247590,\"journal\":{\"name\":\"Bangladesh Heart Journal\",\"volume\":\"6 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-07-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bangladesh Heart Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3329/BHJ.V33I1.37029\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bangladesh Heart Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3329/BHJ.V33I1.37029","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Idiopathic Thrombocytopenic Purpura in Patients with Ischaemic Heart Disease - A Therapeutic Challenge
Idiopathic thrombocytopenic purpura (ITP) and myocardial infarction (MI) in an individual patient is a rare combination. MI mandates thrombolytic and antiplatelet therapy which increases the risk of bleeding in ITP. So far, no guideline deals with management protocol for ischaemic heart disease (IHD) in ITP patients. Here, we describe 2 cases of IHD who developed ITP while on antiplatelet therapy.Bangladesh Heart Journal 2018; 33(1) : 74-77